Our study provided solid evidences of functional differences between two variants; both in vivo and in vitro experiments showed that ITSN1-L had little effect on cell proliferation but could inhibit glioma cells migration and invasion, while ITSN1-S exerted opposite function. This evidence concerns the gene ITSN1 and central nervous system cancer.